Victoria's Secret adopted a shareholder rights plan on Tuesday, after Australian billionaire Brett Blundy's investment firm ...

REYNOLDSBURG, Ohio - Victoria’s Secret & Co. (NYSE: VSCO) heeft de publicatie van haar eerste kwartaalcijfers 2025 en de bijbehorende conference call uitgesteld vanwege een recent beveiligingsincident ...

Victoria's Secret & Co. faces margin pressures and activist challenges amid debt concerns. Click for my look at VSCO post Q1 ...

Victoria's Secret's poison pill comes at a time when the lingerie maker has been grappling with tepid demand, as consumers avoid expensive purchases amid rising tariff uncertainty and fears of an ...

Victoria's Secret's poison pill comes at a time when the lingerie maker has been grappling with tepid demand, as consumers avoid expensive purchases amid rising tariff uncertainty and fears of an ...

Goldman Sachs-analisten hebben woensdag hun verkoopadvies voor het Victoria’s Secret aandeel (NYSE: VSCO) gehandhaafd met een koersdoel van $ 15,00, terwijl het aandeel rond de $ 20,27 noteert. Volgen ...

Victoria’s Secret & Co’s board of directors approved the adoption of a limited-duration shareholder rights plan, or poison pill, to protect the best interest of shareholders, according to a ...

Victoria’s Secret said in a statement. The plan, which is often called a poison pill, will issue one right for each share at the close of business on May 29 and be triggered if an investor ...

Victoria's Secret & Co. Q1 results are expected to ... The main VSCO focus is the hostile takeover attempt by BBRC, countered by a poison pill defense to protect existing shareholders from losing ...

Investing.com -- Shares of Victoria’s Secret & Co. (NYSE:VSCO) closed up 3.3% with an additional 0.5% gain after hours following the company’s announcement of adopting a "poison pill" strategy.